Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Jan 31, 2016

Filed with the SEC on Mar 16, 2016 and accepted by EDGAR at Mar 16, 2016, 10:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2015-11-01 to 2016-01-31$999.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2015-05-01 to 2016-01-31$3.0mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2015-11-01 to 2016-01-31−$2.4mus-gaap:OperatingIncomeLoss
Operating income9 months2015-05-01 to 2016-01-31−$7.8mus-gaap:OperatingIncomeLoss
Income tax3 months2015-11-01 to 2016-01-31$31.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2015-05-01 to 2016-01-31$76.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-11-01 to 2016-01-31−$2.4mus-gaap:NetIncomeLoss
Net income9 months2015-05-01 to 2016-01-31−$7.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-11-01 to 2016-01-31−$0.28us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2015-05-01 to 2016-01-31−$0.90us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-11-01 to 2016-01-31−$0.28us-gaap:EarningsPerShareBasic
Basic EPS9 months2015-05-01 to 2016-01-31−$0.90us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-11-01 to 2016-01-318,702,237 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2015-05-01 to 2016-01-318,702,237 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure9 months2015-05-01 to 2016-01-31$176.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-01-31$3.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-01-31$5.8mus-gaap:AssetsCurrent
Total assetsAt period end2016-01-31$7.1mus-gaap:Assets
Current liabilitiesAt period end2016-01-31$4.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-01-31$4.9mus-gaap:Liabilities
Shareholders' equityAt period end2016-01-31$2.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-16-088331. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.